Thermo Fisher Scientific TMO has unveiled its latest innovation, the spectral-enabled Invitrogen Attune Xenith Flow Cytometer. The solution allows immunology and immuno-oncology researchers to ...

Thermo Fisher Scientific, a $151.8 billion science giant, is struggling on the stock front despite its cutting-edge ...

With a market cap of $151.8 billion, Thermo Fisher Scientific Inc. (TMO) is a global leader in serving science, offering ...

A Black woman in her late 50s alleging job discrimination by Thermo Fisher Scientific Inc. can review a pay equity study it ...

Thermo Fisher Scientific stock may remain sluggish through November. What's behind the weakness and is TMO a buy now?

Thermo Fisher Scientific Inc. closed 35.73% below its 52-week high of $627.88, which the company achieved on September 10th.

Thermo Fisher has unleashed its next-generation TruNarc Delta and Tau Handheld Narcotics Analyzers to help law enforcement ...

Thermo Fisher's updated 2025 guidance shows a $1 EPS, or 4.2% hit from tariffs and government spending cuts. Thermo can mitigate the tariff issues by next year, as its scale gives it options to ...

Thermo Fisher Scientific received site plan approval from the Pease Development Authority to build a new aircraft hangar and office at the Pease International Tradeport. The project includes a two ...

Forbes contributors publish independent expert analyses and insights. Thermo Fisher Scientific provides products and services that support the life sciences industry, including large ...

Thermo Fisher Scientific is expanding its life sciences portfolio by acquiring a division of Solventum that provides technologies and products used in the manufacturing of biologic drugs.